Very young children learn words at a tremendous rate. Now researchers at the Center for Mind and Brain at the University of California, Davis, have for the first time seen how specific brain regions activate as two-year-olds remember new words — while the children were sleeping.
In a new study, researchers have designed a miniaturized 3D-printed device to inactivate Pseudomonas aeruginosa, a common bacterium that causes the infection, according to an article posted on the The Carl R. Woese Institute for Genomic Biology (IGB) website.
The NIH BRAIN Initiative-funded project could help people with paralysis to communicate, and brings hope for greater commercial development of brain-computer interface technology.
Even before the worldwide pandemic, inevitable developments in our field were approaching, presenting both threats and opportunities. This article identifies six of the major developments and highlights the opportunities that could be nurtured for both patients and audiology practices.
Read More
In a new study published in the journal “Development,” USC Stem Cell scientists describe how adult flies can regenerate sensory hearing cells in their antennae, and how studying flies can provide a new way to understand and develop treatments for the hundreds of millions of patients worldwide who live with hearing and balance disorders.
Read More
Creighton University’s Translational Hearing Center has been awarded “the largest National Institutes of Health (NIH) grant in the university’s history,” according to an announcement from the Nebraska-based school.
Read More
Cooling the sensitive tissues of the inner ear before and during a cochlear implant surgery may lead to better hearing outcomes, according to a University of Miami Health System and College of Engineering researcher who is leading a collaborative team developing this therapeutic approach.
Read More
Dr Franck will lead pre-commercial strategy and launch planning for Frequency’s clinical pipeline, including its lead program aimed at developing a restorative treatment for sensorineural hearing loss (SNHL), the most common form of hearing loss.
Read More
The company announced the launch of Widex PureSound technology, available in its new WIDEX MOMENT hearing aids, featuring two distinct signal processing pathways — a “classic” version and a new ZeroDelay Accelerator pathway that “dramatically changes how hearing aids sound,” according to the company.
Read More
The findings are significant because no such FDA-approved drug currently exists, and the drug that has shown effectiveness to protect hearing in animal models in the study, dabrafenib, is an FDA-approved drug that is currently used in treating cancers.
Read More
In her term, Williams will work to advance the objectives of ASHA and its more than 211,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students in communication sciences and disorders.
Read More
A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material “replaces” the genetic defect and enables the cells to continue functioning normally.
Read More
Gentamicin is used in US hospitals to treat a variety of bacterial infections, including infections in newborns and in other susceptible patients, such as those with cystic fibrosis. Yet researchers estimate that up to 20% of patients who are treated with it experience some degree of irreversible hearing loss.
Read More
CSL’s Systems and Networking Research Group (SyNRG) is defining a new sub-area of mobile technology that they call “earable computing.” The team believes that earphones will be the next significant milestone in wearable devices, and that new hardware, software, and apps will all run on this platform
Read More
The drug, called ISRIB, has already been shown in laboratory studies to restore memory function months after traumatic brain injury (TBI), reverse cognitive impairments in Down Syndrome, prevent noise-related hearing loss, fight certain types of prostate cancer, and even enhance cognition in healthy animals.
Read More
In a new column published November 19, 2020 in “The New England Journal of Medicine,” the experts write that the FDA has remained silent after missing the statutory deadline to implement the Over-the-Counter Hearing Aid Act of 2017.
Read More
Researchers at Harvard’s Music Lab have determined that American infants relaxed when played lullabies that were unfamiliar and in a foreign language.
Read More
According to Cochlear, the campaign is supported by 10 hearing health nonprofit and industry partners, and establishes a simple, common metric—defined as 20 decibels in each ear—to help simplify the ongoing conversation and actions related to monitoring hearing health and treating hearing loss, especially among adults 55 years of age and older.
Read More